| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 52.866.306 $ | -29.756.436 $ | -10,1 % | 6 | 82.622.742 $ | -6.289.854 $ | -5,1 % | 6 | 88.912.596 $ | +16.337.353 $ | +75,4 % | 6 | ||||
| ACTUATE THERAPEUTICS, INC. | ACTU | → 0 | Neutral | 27.536.989 $ | -33.968.987 $ | -55,2 % | 1 | 61.505.976 $ | -5.728.497 $ | -8,5 % | 1 | 67.234.473 $ | +6.347.840 $ | +10,4 % | 1 |
| Opus Genetics, Inc. | IRD | → 0 | Schwach | 16.759.602 $ | +9.355.910 $ | +126,4 % | 1 | 7.403.692 $ | +810.354 $ | +12,3 % | 1 | 6.593.338 $ | +3.130.915 $ | +90,4 % | 1 |
| COGNITION THERAPEUTICS INC | CGTX | → 0 | Stark | 4.560.000 $ | -3.540.001 $ | -43,7 % | 1 | 8.100.001 $ | +1 $ | +0,0 % | 1 | 8.100.000 $ | +6.240.000 $ | +335,5 % | 1 |
| Lantern Pharma Inc. | LTRN | → 0 | Schwach | 1.184.276 $ | -1.874.530 $ | -61,3 % | 1 | 3.058.806 $ | -1.359.554 $ | -30,8 % | 1 | 4.418.360 $ | +1.018.352 $ | +30,0 % | 1 |
| Rein Therapeutics, Inc. | RNTX | → 0 | Schwach | 2.577.088 $ | +615.817 $ | +31,4 % | 1 | 1.961.271 $ | +16.907 $ | +0,9 % | 1 | 1.944.364 $ | -422.687 $ | -17,9 % | 1 |
| IN8BIO, INC. | INAB | → 0 | 248.351 $ | -344.645 $ | -58,1 % | 1 | 592.996 $ | -29.065 $ | -4,7 % | 1 | 622.061 $ | +22.933 $ | +3,8 % | 1 | |
| 52.866.306 $ | -29.756.436 $ | -10,1 % | 6 | 82.622.742 $ | -6.289.854 $ | -5,1 % | 6 | 88.912.596 $ | +16.337.353 $ | +75,4 % | 6 | ||||